Hepatic neosporosis in a dog treated for pemphigus foliaceus

J Vet Diagn Invest. 2013 Nov;25(6):807-10. doi: 10.1177/1040638713507257.

Abstract

A 4-year-old, female, spayed Border Collie dog was presented for progressive lethargy, inappetence, and weakness of 4 days duration. The animal had been diagnosed with pemphigus foliaceus 3 months prior and was receiving combination immunosuppressive therapy. Serum biochemistry revealed severely elevated liver enzymes and bilirubin, and humane euthanasia was elected. Gross postmortem examination revealed a diffusely pale tan to slightly yellow, enlarged, markedly friable liver with an enhanced reticular pattern. Histologically, the hepatic changes consisted of multifocal to coalescing areas of severe vacuolar degeneration, numerous coalescing foci of hepatocellular necrosis, and myriad intra- and extracellular protozoa that reacted immunohistochemically with polyclonal antibodies to Neospora caninum, and not Toxoplasma gondii. Neosporosis in the current case is thought to be due to reactivation of latent N. caninum occurring with the administration of glucocorticoid therapy. The severe complication in the present case highlights the importance of early detection and mitigation of common infections in immunosuppressed animals.

Keywords: Azathioprine; Neospora caninum; dogs; immunosuppression; pemphigus foliaceus.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Coccidiosis / parasitology
  • Coccidiosis / pathology
  • Coccidiosis / veterinary*
  • Dog Diseases / parasitology*
  • Dog Diseases / pathology
  • Dogs
  • Fatal Outcome
  • Female
  • Histocytochemistry / veterinary
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Diseases, Parasitic / parasitology
  • Liver Diseases, Parasitic / pathology
  • Liver Diseases, Parasitic / veterinary*
  • Neospora / isolation & purification*
  • Pemphigus / drug therapy
  • Pemphigus / veterinary*

Substances

  • Immunosuppressive Agents